Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Clerson

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
American Heart Journal|December 13, 2005
Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registryNicolas Danchin, Jean-Pierre Cambou, Guy Hanania, et al.
Arthritis and Rheumatism|July 20, 2011
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survivalMarc Humbert, Azzedine Yaici, Pascal de Groote, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2018
The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departmentsOmar Benbrahim, Jean-François Viallard, Sylvain Choquet, et al.
Annales De Cardiologie Et D'Angeiologie|January 18, 2006
[Combination therapy at hospital discharge in the USIC 2000 survey]Aurès Chaib, Viviana Henegariu, Nicolas Danchin, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2007
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy eraOlivier Sitbon, Caroline Lascoux-Combe, Jean-François Delfraissy, et al.
Archives of Cardiovascular Diseases|March 16, 2010
Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in FranceAlain Fraisse, Xavier Jais, Jean-Marc Schleich, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
The Journal of Rheumatology|June 3, 2009
Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie)Kiet Phong Tiev, Elisabeth Diot, Pierre Clerson, et al.
Rheumatology (Oxford, England)|February 11, 2010
Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcomeEric Hachulla, David Launay, Azzedine Yaici, et al.
The Clinical Neuropsychologist|August 5, 2014
Validation of the Test Your Memory (F-TYM Test) in a French memory clinic populationNicolas Postel-Vinay, Olivier Hanon, Pierre Clerson, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
American Heart Journal|December 13, 2005
Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registryNicolas Danchin, Jean-Pierre Cambou, Guy Hanania, et al.
Arthritis and Rheumatism|July 20, 2011
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survivalMarc Humbert, Azzedine Yaici, Pascal de Groote, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2018
The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departmentsOmar Benbrahim, Jean-François Viallard, Sylvain Choquet, et al.
Annales De Cardiologie Et D'Angeiologie|January 18, 2006
[Combination therapy at hospital discharge in the USIC 2000 survey]Aurès Chaib, Viviana Henegariu, Nicolas Danchin, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2007
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy eraOlivier Sitbon, Caroline Lascoux-Combe, Jean-François Delfraissy, et al.
Archives of Cardiovascular Diseases|March 16, 2010
Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in FranceAlain Fraisse, Xavier Jais, Jean-Marc Schleich, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
The Journal of Rheumatology|June 3, 2009
Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie)Kiet Phong Tiev, Elisabeth Diot, Pierre Clerson, et al.
Rheumatology (Oxford, England)|February 11, 2010
Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcomeEric Hachulla, David Launay, Azzedine Yaici, et al.
The Clinical Neuropsychologist|August 5, 2014
Validation of the Test Your Memory (F-TYM Test) in a French memory clinic populationNicolas Postel-Vinay, Olivier Hanon, Pierre Clerson, et al.
Pageof 6